Charlene A. Banard - Net Worth and Insider Trading
Charlene A. Banard Net Worth
The estimated net worth of Charlene A. Banard is at least $190,447 dollars as of 2024-04-27. Charlene A. Banard is the EVP, Chief Technical Officer of Atara Biotherapeutics Inc and owns about 276,010 shares of Atara Biotherapeutics Inc (ATRA) stock worth over $190,447. Details can be seen in Charlene A. Banard's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Charlene A. Banard has not made any transactions after 2023-05-16 and currently still holds the listed stock(s).
Transaction Summary of Charlene A. Banard
Charlene A. Banard Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Charlene A. Banard owns 2 companies in total, including Applied Molecular Transport Inc (AMTI) , and Atara Biotherapeutics Inc (ATRA) .
Click here to see the complete history of Charlene A. Banard’s form 4 insider trades.
Insider Ownership Summary of Charlene A. Banard
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| AMTI | Applied Molecular Transport Inc | 2022-03-31 | director |
| ATRA | Atara Biotherapeutics Inc | 2023-05-16 | EVP & Chief Technical Officer |
Charlene A. Banard Latest Holdings Summary
Charlene A. Banard currently owns a total of 1 stock. Charlene A. Banard owns 276,010 shares of Atara Biotherapeutics Inc (ATRA) as of May 16, 2023, with a value of $190,447.
Latest Holdings of Charlene A. Banard
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ATRA | Atara Biotherapeutics Inc | 2023-05-16 | 276,010 | 0.69 | 190,447 |
Holding Weightings of Charlene A. Banard
Charlene A. Banard Form 4 Trading Tracker
According to the SEC Form 4 filings, Charlene A. Banard has made a total of 1 transactions in Atara Biotherapeutics Inc (ATRA) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Atara Biotherapeutics Inc is the sale of 19,040 shares on May 16, 2023, which brought Charlene A. Banard around $38,842.
Insider Trading History of Charlene A. Banard
- 1
Charlene A. Banard Trading Performance
Charlene A. Banard Ownership Network
Ownership Network List of Charlene A. Banard
Ownership Network Relation of Charlene A. Banard
Charlene A. Banard Owned Company Details
What does Applied Molecular Transport Inc do?
Who are the key executives at Applied Molecular Transport Inc?
Charlene A. Banard is the director of Applied Molecular Transport Inc. Other key executives at Applied Molecular Transport Inc include Chief Financial Officer Shawn Cross , director & Chief Executive Officer Mahmood Tahir Ph.d. , and VP & Finance & Bus. Ops. Brandon Hants .
Applied Molecular Transport Inc (AMTI) Insider Trades Summary
Over the past 18 months, Charlene A. Banard made no insider transaction in Applied Molecular Transport Inc (AMTI). Other recent insider transactions involving Applied Molecular Transport Inc (AMTI) include a net sale of 478,573 shares made by Mahmood Tahir Ph.d. , a net sale of 404,661 shares made by Shawn Cross , and a net sale of 224,060 shares made by Brandon Hants .
In summary, during the past 3 months, insiders sold 0 shares of Applied Molecular Transport Inc (AMTI) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 1,116,450 shares of Applied Molecular Transport Inc (AMTI) were sold and 150,000 shares were bought by its insiders, resulting in a net sale of 966,450 shares.
Applied Molecular Transport Inc (AMTI)'s detailed insider trading history can be found in Insider Trading Tracker table.
Applied Molecular Transport Inc Insider Transactions
Charlene A. Banard Mailing Address
Above is the net worth, insider trading, and ownership report for Charlene A. Banard. You might contact Charlene A. Banard via mailing address: C/o Applied Molecular Transport Inc., 450 East Jamie Court, South San Francisco Ca 94080.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
